HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiangyu Fan Selected Research

Chlorides

10/2021Neuroprotective Effect of Alpha-asarone on the Rats Model of Cerebral Ischemia-Reperfusion Stroke via Ameliorating Glial Activation and Autophagy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiangyu Fan Research Topics

Disease

4Neoplasms (Cancer)
01/2023 - 01/2020
4Infections
01/2023 - 01/2013
3Tuberculosis (Tuberculoses)
12/2019 - 01/2014
2Inflammation (Inflammations)
01/2022 - 09/2021
2Epilepsy (Aura)
10/2021 - 10/2021
1Pleural Effusion (Pleural Effusions)
01/2023
1Malignant Pleural Effusion
01/2023
1Lung Neoplasms (Lung Cancer)
01/2023
1Hypoxia (Hypoxemia)
01/2022
1Pathologic Neovascularization
01/2022
1Stroke (Strokes)
10/2021
1Brain Ischemia (Cerebral Ischemia)
10/2021
1Infarction (Infarctions)
10/2021
1Hepatocellular Carcinoma (Hepatoma)
09/2021
1Liver Neoplasms (Liver Cancer)
09/2021
1Corneal Neovascularization
09/2021
1Foreign-Body Reaction
09/2021
1Foreign Bodies (Foreign Body)
09/2021
1Astigmatism
06/2021
1Amblyopia (Lazy Eye)
06/2021
1Breast Neoplasms (Breast Cancer)
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Glioma (Gliomas)
01/2020
1Stomach Neoplasms (Stomach Cancer)
01/2018
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2016
1Extensively Drug-Resistant Tuberculosis
01/2016

Drug/Important Bio-Agent (IBA)

4Anti-Bacterial Agents (Antibiotics)IBA
12/2019 - 01/2013
3MicroRNAs (MicroRNA)IBA
01/2020 - 01/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 09/2021
2Neuroprotective AgentsIBA
10/2021 - 10/2021
1Chemokine CXCL13IBA
01/2023
1ImmunosorbentsIBA
01/2023
1Indicators and Reagents (Reagents)IBA
01/2023
1ChemokinesIBA
01/2023
1NitrogenIBA
01/2023
1EnzymesIBA
01/2023
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2022
1piperlongumineIBA
01/2022
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2022
1asaroneIBA
10/2021
1ChloridesIBA
10/2021
1Silicon Dioxide (Silica)FDA LinkGeneric
09/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2021
1Cisplatin (Platino)FDA LinkGeneric
09/2021
1Bevacizumab (Avastin)FDA Link
09/2021
1Capsules (Microcapsules)IBA
09/2021
1ChitosanIBA
09/2021
1Long Noncoding RNAIBA
01/2020
1CarcinogensIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
13' Untranslated Regions (3' UTR)IBA
01/2020
1Amino AcidsFDA Link
12/2019
1AcetyltransferasesIBA
12/2019
1RNA (Ribonucleic Acid)IBA
01/2016
1Mycolic Acids (Mycolic Acid)IBA
01/2016
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2014

Therapy/Procedure

2Therapeutics
09/2021 - 01/2016
1Transplantation
09/2021
1Duration of Therapy
06/2021
1Sutures (Suture)
06/2021
1Phage Therapy
09/2016